+Vote!
World of stocks (Free subscription) | yesterday
TheStreet.com Winners & Losers Tech Winners & Losers: SanDisk Financial Winners & Losers: Merrill Lynch 9/5/2008 12:02 PM EDT Health Winners & Losers: Amylin 9/5/2008 4:55 PM EDT Stocks Fight Their Way Back to a Positive Finish 9/5/2008 4:33 PM EDT 10 Best, 10 Worst Technology Funds Companies, consumers rein in spending, putting a dent in tech funds. 9/5/2008 5:05 PM EDT Fannie Mae, Freddie Mac Bailout...
+Vote!
The Street (Free subscription) | 09/02/2008
The outlook for the diabetes drug worsens on side-effect worries and rising competition.
+Vote!
World of stocks (Free subscription) | 08/28/2008
TheStreet.com Winners & Losers Tech Winners & Losers: Dell Financial Winners & Losers: MBIA 8/28/2008 12:21 PM EDT Health Winners & Losers: Amylin 8/28/2008 4:30 PM EDT Dell's Profit Pinched (Update) 8/28/2008 5:17 PM EDT Novell's Quarterly Loss Widens Auction-rate securities ruin the bottom line. 8/28/2008 5:01 PM EDT Marvell's Quarter Shines The chipmaker meets estimates for profit and revenue 8/28/2008...
1Vote!
Business Week (Free subscription) | 08/28/2008
Movers: Fannie Mae, Freddie Mac, Lehman, Amylin, Dollar Tree, J.CrewStocks in the news Wednesday From Fannie Mae () announces management changes. The mortgage company's chief financial officer, Stephen Swad, was replaced and the chief business officer, Peter Niculescu, will take on an expanded role. It appointed a new chief financial officer and chief risk officer. CEO Daniel Mudd will remain in place....
+Vote!
The Street (Free subscription) | 08/28/2008
Shares were jumping more than 7% after being beaten down by concerns about diabetes drug Byetta.
+Vote!
The Street (Free subscription) | 08/28/2008
Shares were jumping more than 7% after being beaten down by concerns about diabetes drug Byetta.
+Vote!
Market Watch (Free subscription) | 08/28/2008
Drug stocks gain in early action Thursday as shares of Amylin Pharmaceuticals rise after being pummeled Wednesday by negative news about its diabetes drug Byetta.
1Vote!
Market Watch (Free subscription) | 08/28/2008
BOSTON (MarketWatch) -- Drug stocks gained in early action Thursday as shares of Amylin Pharmaceuticals moved higher after being pummeled on Wednesday by negative news about its diabetes drug Byetta. The Amex Pharmaceutical Index rose 0.7% to 312.7 and the Amex Biotechnology Index [s:$btk] advanced 0.3% to 825.8. Shares of Amylin were up 5% at $21.42. The stock tumbled almost 25% on Wednesday after...
+Vote!
The Street (Free subscription) | 08/27/2008
The stocks falls 25% Wednesday as Wall Street opines on recent cases of pancreatitis and deaths in patients taking the company's diabetes drug.
+Vote!
MarketBeat (Free subscription) | 08/27/2008
Shares of Amlyin Pharmaceuticals have been hit hard Wednesday, falling 26% after the company, along with its partner Eli Lilly, announced that four patients who took the company’s diabetes drug, Byetta, had died of pancreatitis. This follows a similar report of two deaths from the FDA last week. Several analysts have [...]
1Vote!
The Business Courier of Cincinnati (Free subscription) | 08/27/2008
A diabetes drug Amylin Pharmaceuticals Inc. plans to manufacture in West Chester has been implicated in six patient deaths, causing the drug maker’s stock price to plummet. (AMLN)
+Vote!
Smart Money (Free subscription) | 08/27/2008
Borders and Ikon printed surprising gains. But fatal complications haunted Amylin.
1Vote!
Seeking Alpha (Free subscription) | 08/27/2008
A. Reza Saadat submits: On Tuesday August 26, Amylin ( AMLN ) and its partner Eli Lilly ( LLY ) announced that four patients had died while on diabetes treatment Byetta . Both Amylin (down 12%) and Lilly (down 1%) sold off in after hours following repeated headlines saying Byetta was responsible for the deaths. Complete Story »
